MedPath

A clinical trial to study the effects of seven sequences of Pranayama and oral hypoglycemic drugs versus only oral hypoglycemic drugs in type 2 diabetes mellitus.

Phase 3
Registration Number
CTRI/2010/091/000188
Lead Sponsor
Patanjali Ayurved Ltd.Address: Plot no. D-38, Hardwar industrial area,Hardwar -249 401
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
28
Inclusion Criteria

Patient with Established type 2 diabetes (duration 1-10 years), on oral hypoglycemic agents (like Metformin or Glibenclamide) willing to participate in the study; Between 18-60 years.

Exclusion Criteria

Patient on insulin or patients with diabetic complications like neuropathy, retinopathy, nephropathy, diabetic foot, chronic ulcer and cardiovascular diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath